Xtandi 40 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DX25F6XJY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On June 2, 2025, the Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. The delivery order calls for the supply of Xtandi 40 mg tablets (120-count units), an oncology medication used in prostate cancer treatment. This award was issued on a firm fixed-price basis with an ultimate completion date of June 3, 2025 and carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on equal footing with other qualified vendors in the federal marketplace.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which carries a ceiling value of $499,999,999 and extends through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide, including prescription medications, biologics, over-the-counter products, and medical consumables. The award demonstrates DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, providing direct distribution of prescription drugs to Department of Defense healthcare sites across the nation.
Quick answers
Who was awarded contract SPE2DX25F6XJY?
SPE2DX25F6XJY was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on June 2, 2025.
How much is contract SPE2DX25F6XJY worth?
The government has obligated $4,170 on SPE2DX25F6XJY.
Is contract SPE2DX25F6XJY an order under another contract?
Yes. SPE2DX25F6XJY is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XJY competed?
The extent of competition for SPE2DX25F6XJY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award